Analystreport

Vascular Biogenics Ltd (NASDAQ: VBLT) had its price target raised by analysts at Oppenheimer Holdings Inc. from $2.00 to $3.00. They now have an "outperform" rating on the stock.

Vascular Biogenics Ltd. - Ordinary Shares  (VBLT) 
Last vascular biogenics ltd. - ordinary shares earnings: 11/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: vblrx.com